Clinical Trial Update: Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating efficacy, safety and tolerability of cadazolid for Clostridioides difficile infection has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Cadazolid (cadazolid)

Snippet

Sponsor: Actelion | Conditions: Clostridium Difficile Infection | Phase 2 | Status: COMPLETED